Cardiovascular Disease Specimen Repository


About this study

The purpose of the study is collect specimens for future studies to identify markers circulating in the blood that are associated with the development of further complications of heart disease.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Subjects currently without a specimen in the cardiovascular disease repository
  • Subjects diagnosed with Heart failure from 2006 to present who reside in the 5 county area

Subjects meeting the troponin criteria, reside in the 7-county area, and currently do not have a DNA specimen in the Cardiovascular Disease Specimen Repository or any of the following studies IRB #s 632-01, 2346-02, 1194-05, and 07-0060760. 

  • Subjects who have undergone PCI or CABG from 2002 through August 2013 
  • Those who undergo PCI or CABG
  • Subjects with atrial fibrillation identified in the retrospective study IRB #11-003629

Exclusion Criteria:

  • Not eligible for venipuncture

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Suzette Bielinski, Ph.D., M.Ed.

Closed-enrolling by invitation

What is this? (?)
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Ellen Koepsell R.N.

(507) 538-0047

More information


Publications are currently not available

Mayo Clinic Footer